Reliability and validity of the M.D. Anderson symptom inventory (MDASI-BT) in the primary brain tumor patient population.

被引:0
|
作者
Armstrong, T
Mendoza, T
Cohen, M
Morrissey, M
Cleeland, C
Gilbert, M
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] UT, Houston Sch Nursing, Houston, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
194
引用
收藏
页码:476 / 477
页数:2
相关论文
共 37 条
  • [21] Chinese version of the M.D. Anderson Symptom Inventory - Validation and application of symptom measurement in cancer patients
    Wang, XS
    Wang, Y
    Guo, H
    Mendoza, TR
    Hao, XS
    Cleeland, CS
    CANCER, 2004, 101 (08) : 1890 - 1901
  • [22] Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory (MDASI-LC)
    Mendoza, Tito R.
    Wang, Xin Shelley
    Palos, Guadalupe
    Lu, Charles
    Liao, Zhongxing
    Mobley, Gary
    Kapoor, Shitij
    Cleeland, Charles S.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 18 - 18
  • [23] Cancer-related symptom assessment in Russia: Validation and utility of the Russian M.D. Anderson symptom inventory
    Ivanova, MO
    Ionova, TI
    Kalyadina, SA
    Uspenskaya, OS
    Kishtovich, AV
    Guo, H
    Mendoza, TR
    Novik, A
    Cleeland, CS
    Wang, XS
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 30 (05) : 443 - 453
  • [24] Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation
    A. Greco
    E. Orlandi
    A. Mirabile
    S. Takanen
    C. Fallai
    N. A. Iacovelli
    A. Rimedio
    E. Russi
    M. Sala
    D. Monzani
    D. I. Rosenthal
    G. B. Gunn
    P. Steca
    L. Licitra
    P. Bossi
    Supportive Care in Cancer, 2015, 23 : 3465 - 3472
  • [25] Symptom assessment in patients with chronic lymphocytic leukemia: Validation and application of the M.D. Anderson Symptom Inventory.
    Wang, XS
    Ferrajoli, A
    Broadway, JB
    Mobley, GM
    Mendoza, TR
    Keating, MJ
    Cleeland, C
    BLOOD, 2005, 106 (11) : 331B - 331B
  • [26] Utility of the of the M. D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation (CRT) in patients with gastrointestinal malignancies
    Janjan, N. A.
    Wang, X. S.
    Mendoza, T.
    Zhang, Y.
    Das, P.
    Crane, C.
    Delclos, M.
    Krishnan, S.
    Cleeland, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Reliability and validity testing of the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF): A pilot study of an evaluative instrument for symptom identification in heart failure patients with cancer
    Fadol, Anecita P.
    Kernicki, Jeanette G.
    Lenihan, Daniel J.
    Mendoza, Tito
    Cleeland, Charles S.
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S116 - S116
  • [28] Validity and utility of the M. D. Anderson Symptom Inventory (MDASI) among prostate cancer patients: data from E2Z02: symptom outcomes and practice patterns (SOAPP)
    Mendoza, Tito R.
    Zhao, Fengmin
    Patrick-Miller, Linda J.
    Cleeland, Charles S.
    Wagner, Lynne I.
    Fisch, Michael
    QUALITY OF LIFE RESEARCH, 2012, 21 : 16 - 16
  • [29] Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C)
    Chen, Ren-wang
    Yang, Sheng-li
    Xu, Zhong-yu
    Peng, Miao
    Chen, Meng-ni
    Wang, Qiu-shuang
    Chang, Jian
    Hu, Jian-li
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (04) : 820 - 827
  • [30] Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory
    Mendoza, Tito R.
    Wang, Xin Shelley
    Lu, Charles
    Palos, Guadalupe R.
    Liao, Zhongxing
    Mobley, Gary M.
    Kapoor, Shitij
    Cleeland, Charles S.
    ONCOLOGIST, 2011, 16 (02): : 217 - 227